151 related articles for article (PubMed ID: 28468582)
1. The prognostic value of p53 positive in colorectal cancer: A retrospective cohort study.
Wang P; Liang J; Wang Z; Hou H; Shi L; Zhou Z
Tumour Biol; 2017 May; 39(5):1010428317703651. PubMed ID: 28468582
[TBL] [Abstract][Full Text] [Related]
2. p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.
Zeng ZS; Sarkis AS; Zhang ZF; Klimstra DS; Charytonowicz E; Guillem JG; Cordon-Cardo C; Cohen AM
J Clin Oncol; 1994 Oct; 12(10):2043-50. PubMed ID: 7931472
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
[TBL] [Abstract][Full Text] [Related]
5. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
7. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
8. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
Huh JW; Kim HR; Kim YJ
J Am Coll Surg; 2013 Jun; 216(6):1063-9. PubMed ID: 23571142
[TBL] [Abstract][Full Text] [Related]
10. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
[TBL] [Abstract][Full Text] [Related]
12. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
14. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
Yuan H; Tu SL; He XJ
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
[TBL] [Abstract][Full Text] [Related]
16. [Impact of macroscopic enlarged lymph node on stage II colorectal cancer prognosis and its potential mechanism].
Fan W; Huang Z; Fang Y; Wan D; Pan Z; Li L
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):558-62. PubMed ID: 26108768
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of International Union Against Cancer pN Staging and Lymph Node Ratio in Node-Positive Colorectal Cancer after Advanced Lymph Node Dissection.
Märkl B; Olbrich G; Schenkirsch G; Kretsinger H; Kriening B; Anthuber M
Dis Colon Rectum; 2016 May; 59(5):386-95. PubMed ID: 27050600
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]